Your session is about to expire
← Back to Search
Dexamethasone Insert vs Steroid Drops for Postoperative Inflammation
Study Summary
This trial will compare the efficacy of two treatments for inflammation following vitreoretinal surgery. One group will receive a dexamethasone insert and the other group will receive topical steroid drops.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I experience eye pain in the study eye.You are allergic to NSAIDs, steroids, or any part of the study medication.I have used steroids in the past 14 days.I have had issues or diseases in my tear duct area.I have glaucoma but it's controlled with one medication.You are currently taking strong pain medications.My eye has signs of inflammation.I am over 18 years old.My eyelid turns inward or outward due to its structure.I have used NSAID eye drops, creams, or pills within the last week and during surgery.I am scheduled for eye surgery to fix a macular hole, remove an epiretinal membrane, or address vitreomacular traction.I have had surgery with small instruments.I am having eye surgery for cataract, glaucoma, lens exchange, or a drug implant.I have not had eye surgery or procedures in the last 6 months.I do not have uncontrolled eye or body inflammation, including diabetes.I have had complications during surgery.I have used NSAIDs or steroids in my eye during surgery.
- Group 1: Topical steroid drop group
- Group 2: Intracanalicular dexamethasone insert group
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA accepted Dexamethasone Ophthalmic Insert as a legitimate medication?
"There is ample evidence supporting the safety of Dexamethasone Ophthalmic Insert, so this treatment receives a score of 3. This drug has been approved by relevant authorities after numerous successful trials in phase 4."
What is the participant count of this clinical trial?
"Unfortunately, this clinical trial has ceased its search for participants. Initially advertised on December 1st 2020 and last updated February 24th 2022, individuals interested in similar studies may refer to 837 different trials involving vitreoretinal surgery or 556 that involve Dexamethasone Ophthalmic Inserts."
Are there any open recruitment slots available for this scientific experiment?
"According to clinicaltrials.gov, the initial listing for this trial was posted on December 1st 2020 and has not been updated since February 24th 2022. Therefore, it is not presently enrolling participants; however, there are 1393 other medical studies seeking patients at the current moment in time."
Has Dexamethasone Ophthalmic Insert been examined in any prior experiments?
"Presently, there are 556 active studies involving Dexamethasone Ophthalmic Insert with 145 trials in the third phase. Most of these investigations take place in Mishawaka, Indiana; however, research is being conducted at 18,626 different sites worldwide."
What medical conditions can be alleviated with the administration of Dexamethasone Ophthalmic Insert?
"Dexamethasone Ophthalmic Insert is typically used to manage ophthalmia, sympathetic. It has also been found helpful in treating branch retinal vein occlusion, bacterial eye infections and macular edema."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger